Document Detail


Rhabdomyolysis connected with the use of bupropion.
MedLine Citation:
PMID:  15370798     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To report an observation dealing with a possible side effect of a smoking cessation drug. DESIGN: A case report. STUDY PERSON: A 34-year old man who had been treated with slow-release bupropion for smoking cessation. OBSERVATION: After 5 days of treatment the patient suffered severe muscular pain and the diagnosis of rhabdomyolysis was confirmed. CONCLUSION: Rhabdomyolysis is a rare complication when treating with slow-release bupropion for smoking cessation.
Authors:
Francesc Bobé; Maria Eugenia Buil; Laura Palacios
Related Documents :
1923078 - Antibiotic treatment of otitis media with effusion.
6179548 - Palliative treatment of tardive dyskinesia with combination of amantadine-neuroleptic a...
576528 - Five cases of absence of iodide concentrating mechanism.
25404578 - Cochrane in context: schedules for home visits in the early postpartum period.
11619198 - Does bromide cause conversion of epilepsy to psychosis?
18629768 - Hepatic haemangioendothelioma: a vertical association with biliary atresia?
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Scandinavian journal of primary health care     Volume:  22     ISSN:  0281-3432     ISO Abbreviation:  Scand J Prim Health Care     Publication Date:  2004 Sep 
Date Detail:
Created Date:  2004-09-16     Completed Date:  2005-02-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8510679     Medline TA:  Scand J Prim Health Care     Country:  Norway    
Other Details:
Languages:  eng     Pagination:  191-2     Citation Subset:  IM    
Affiliation:
ABS Salou, Institute of Catalan Health, ES-43840 Salou, Tarragona, Spain. elsmua@comt.es
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Bupropion / adverse effects*
Humans
Male
Rhabdomyolysis / chemically induced*
Smoking / drug therapy*
Smoking Cessation / methods
Chemical
Reg. No./Substance:
34841-39-9/Bupropion

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Can brain natriuretic peptide (BNP) be used as a screening tool in general practice?
Next Document:  Effects of transforming growth factor-beta 1 on the early stages of healing of the Achilles tendon i...